VYNE Therapeutics Inc.
VYNE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,280 | -$5,755 | -$8,611 | -$12,022 |
| Dep. & Amort. | $6 | $6 | $6 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $487 | $529 | $763 | $699 |
| Change in WC | -$159 | -$5,369 | -$3,295 | $2,865 |
| Other Non-Cash | -$150 | -$214 | -$324 | -$541 |
| Operating Cash Flow | -$7,096 | -$10,803 | -$11,461 | -$8,999 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$117 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$6,798 | -$9,575 | -$13,769 | -$10,045 |
| Inv. Sales/Matur. | $11,200 | $14,250 | $33,600 | $22,900 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $4,402 | $4,675 | $19,831 | $12,738 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | -$34 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$7 | $0 | -$87 | -$132 |
| Financing Cash Flow | -$7 | -$34 | -$87 | -$132 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$2,701 | -$6,162 | $8,283 | $3,607 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $22,047 | $28,209 | $19,926 | $16,319 |
| End Cash | $19,346 | $22,047 | $28,209 | $19,926 |
| Free Cash Flow | -$7,096 | -$10,803 | -$11,461 | -$9,116 |